NERM
CVS icon

New England Research & Management’s CVS Health CVS Stock Holding History

New England Research & Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,045
Closed -$1.21M – 166
2022
Q2 		$1.21M Buy
13,045
+7,850
+151% +$766K 0.7% 46
2022
Q1 		$526K Buy
5,195
+50
+1% +$5.25K 0.27% 104
2021
Q4 		$531K Hold
5,145
– – 0.26% 107
2021
Q3 		$437K Sell
5,145
-12,965
-72% -$1.09M 0.23% 115
2021
Q2 		$1.51M Sell
18,110
-6,487
-26% -$531K 0.78% 47
2021
Q1 		$1.85M Buy
24,597
+19,162
+353% +$1.4M 1.01% 28
2020
Q4 		$371K Sell
5,435
-3,800
-41% -$247K 0.23% 114
2020
Q3 		$539K Sell
9,235
-16,265
-64% -$1.01M 0.39% 87
2020
Q2 		$1.66M Sell
25,500
-700
-3% -$44.1K 1.19% 19
2020
Q1 		$1.55M Buy
26,200
+2,316
+10% +$155K 1.33% 18
2019
Q4 		$1.77M Sell
23,884
-4,116
-15% -$289K 1.19% 19
2019
Q3 		$1.77M Sell
28,000
-6,950
-20% -$412K 1.28% 16
2019
Q2 		$1.9M Buy
34,950
+1,300
+4% +$70K 1.29% 17
2019
Q1 		$1.81M Buy
33,650
+12,650
+60% +$781K 1.23% 20
2018
Q4 		$1.38M Buy
+21,000
New +$1.57M 1.08% 25
2017
Q3 		– Sell
-2,705
Closed -$218K – 163
2017
Q2 		$218K Sell
2,705
-11,525
-81% -$910K 0.16% 148
2017
Q1 		$1.12M Buy
14,230
+150
+1% +$12K 0.86% 36
2016
Q4 		$1.11M Sell
14,080
-805
-5% -$65.1K 0.87% 31
2016
Q3 		$1.32M Buy
14,885
+4,200
+39% +$396K 1.11% 20
2016
Q2 		$1.02M Buy
10,685
+1,300
+14% +$130K 0.88% 37
2016
Q1 		$974K Sell
9,385
-625
-6% -$60.8K 0.83% 38
2015
Q4 		$979K Buy
10,010
+4,400
+78% +$431K 0.85% 33
2015
Q3 		$541K Buy
+5,610
New +$590K 0.51% 70

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

New England Research & Management's CVS Position: Q3 2022 in Review

New England Research & Management sold out of CVS Health (CVS) in Q3 2022, closing a stake of 13,045 shares — an estimated $1.21M sold.

New England Research & Management first reported a position in CVS in Q3 2015 and held it in 23 quarters. The position peaked at $1.9M in Q2 2019. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • New England Research & Management reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
  • New England Research & Management sold 13,045 CVS Health shares in Q3 2022, an estimated $1.21M.
  • New England Research & Management first reported a position in CVS Health in Q3 2015 and held it in 23 quarters.
  • New England Research & Management's CVS Health position peaked at $1.9M in Q2 2019.
  • 2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.